Viewing Study NCT06452433


Ignite Creation Date: 2025-12-25 @ 2:43 AM
Ignite Modification Date: 2025-12-31 @ 7:14 PM
Study NCT ID: NCT06452433
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-06-11
First Post: 2024-06-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Gumarontinib Combined With 3rd EGFR-TKI in Patients With Non-small Cell Lung Cancer.
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2024-06-01
Start Date Type: ESTIMATED
Primary Completion Date: 2027-12-12
Primary Completion Date Type: ESTIMATED
Completion Date: 2028-02-02
Completion Date Type: ESTIMATED
First Submit Date: 2024-06-05
First Submit QC Date: None
Study First Post Date: 2024-06-11
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-06-05
Last Update Post Date: 2024-06-11
Last Update Post Date Type: ACTUAL